tldrdailynews.com logo

Boston Scientific's $3.7 Billion Acquisition of Axonics

1 min read
Source: Mass Device
Boston Scientific's $3.7 Billion Acquisition of Axonics
Photo: Mass Device
TL;DR

Boston Scientific has agreed to acquire Axonics for approximately $3.7 billion, aiming to strengthen its urology business and expand into the high-growth sacral neuromodulation market. Axonics, based in California, develops neuromodulation systems for urinary and bowel dysfunction treatment. The acquisition is expected to be completed in the first half of 2024, with Boston Scientific projecting a highly accretive impact on its urology business in 2024. This move aligns with Boston Scientific's strategy of pursuing M&A to reinforce category leadership and enter faster growth markets.

Topics:businessbusiness-and-finance#acquisition#axonics#boston-scientific#business-and-finance#medical-technology#neuromodulation
Share this article
  1. Boston Scientific to acquire Axonics for $3.7B  Mass Device
  2. Boston Scientific to Acquire Axonics For About $3.7 Billion  The Wall Street Journal
  3. Boston Scientific Announces Agreement to Acquire Axonics, Inc.  PR Newswire
  4. Medical device maker Boston Scientific to buy Axonics for $3.7 billion  Reuters
  5. Boston Scientific acquires urology company Axonics for $3.7 billion  STAT

Want the full story? Read the original reporting

Read on Mass Device